- Q1 2024 scPharmaceuticals Inc Earnings Call TranscriptMay 14, 2024$4.5 (+3.45%)Earnings
- Q4 2023 scPharmaceuticals Inc Earnings Call TranscriptMar 13, 2024$5.44 (+1.49%)Earnings
- Q2 2023 scPharmaceuticals Inc Earnings Call TranscriptAug 10, 2023$7.75 (-1.27%)Earnings
- scPharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- scPharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 06, 2023
- Q1 2023 scPharmaceuticals Inc Earnings Call TranscriptMay 10, 2023$11.36 (+0.80%)Earnings
- Q4 2022 scPharmaceuticals Inc Earnings Call TranscriptMar 22, 2023$6.92 (-0.14%)Earnings
- scPharmaceuticals Inc at Cowen Health Care Conference TranscriptMar 08, 2023
- scPharmaceuticals Inc at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 16, 2023
- scPharmaceuticals Inc at Jefferies London Healthcare Conference TranscriptNov 16, 2022
- Q3 2022 scPharmaceuticals Inc Earnings Call TranscriptNov 09, 2022$5.38 (-4.44%)Earnings
scPharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Fantastic. Thanks, Glen, and thanks for hosting us. Yeah. It's really exciting time for us. scPharmaceuticals -- really the name says it all. SC stands for subcutaneous. We use subcutaneous technology, technology we've developed, to deliver drugs that have already been proven safe and effective. But are given in the hospital, which as everyone knows, is the single most, highest cost setting of care. And it's also kind of where the patients have the worse outcomes.
So we've been able to use our technology to take our first product, which is called FUROSCIX. It's a drug-device combination and treats New York Heart Association, Class II and Class III heart failure by reformulating the drug from the IV furosemide into a stable pH-neutral form called FUROSCIX and then developing a way, working with West Pharmaceuticals to deliver a five-hour -- it's got a bolus for the first hour and then four hours of continuous infusion.
We've been able to match, almost identical, the PK profile of the IV. Why is that so important? So right now,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)